[1]
Iyngkaran P, Hare DL. Heart Failure Paradigms in the Developed World - A Reflection - Part 1. Curr Cardiol Rev 2021; 17(5)e221021197368
[2]
Iyngkaran P, Hanna F, Horowitz JD, de Courten MP. Contextualising evidence based medicine in determining the key root for translational effectiveness for chronic disease self-management and heart failure. Rev Cardiovasc Med 2022; 23(1): 37.
[3]
McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Euro Heart J 2021; 42(36): 3599-726.
[4]
Iyngkaran P, Hespe C, Hanna F, et al. Part 2: The Wider Considerations in Closing Chronic Disease Gaps – Focus on Heart Failure and Implementation. Current Card Rev 2022.
[5]
Azad A, Hanna F, Battersby M, Iyngkaran P, de Courten MP. Perspectives on ‘Phase V’ or Logistics and regression, as logical progression for Community Heart Failure Triage. Curr Cardiol Rev 2021.
[6]
Quah JX, Dharmaprani D, Tiver K, McGavigan AD, Ganesan AN. Impact of racial differences on the epidemiology and clinical outcomes of atrial fibrillation. Curr Card Rev 2022.
[7]
Satici S, Iyngkaran P, Battersby M, Andrew S, de Courten M. Defining vulnerable patients with heart failure: Opportunistic lessons from Covid-19. Curr Cardiol Rev 2021.
Article Metrics
10
1